An ever-growing amount of healthcare and life sciences data is being generated from a widening variety of sources, such as medical practices, laboratories, pharmaceutical companies, payers, electronic health records and imaging systems, and the proliferation of IoT devices. Failing to properly…
Source: www.healthcareitnews.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
